Krishna Institute of Medical Sciences Limited

BSE: KIMS543308ISIN INE967H01025

Healthcare
Hospital
BSE 500

BSE listing

Share price

₹811.00+19.55 (+2.47%)

as of 18 Sep 2026

52W high: ₹858.15
52W low: ₹575.55
Off 52W high: -5.49%
1M return: +2.84%
3M return: +0.79%
6M return: +25.33%
1Y return: +9.42%
20D avg volume: 73,232
50 DMA: ₹788.99
200 DMA: ₹716.78

Key ratios Consolidated

Market cap: ₹34,063 Cr
Current price: ₹811.00
52W high / low: ₹858.15 / ₹575.55
Face value: ₹2.00
P/E: 175.22
P/B: —
EPS (TTM): ₹4.63
Book value / share: —
ROE: —
ROCE: 8.20%
Operating margin: —
Net margin: —
Debt / equity: 1.27
Net debt: ₹3,189 Cr
Interest cover: 2.64
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 30.7 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	1,180	1,075	997.70	960.70	871.60	796.90	772.40	777.30	688.40	633.80	605.84	652.48
	16.40	9.70	5.20	4.20	7.10	4.50	17.80	5.00	4.60	3.81	3.25	2.88
	1,140	1,021	934.30	867.80	765.00	678.20	655.60	620.10	565.90	537.48	506.52	516.73
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	260.90	235.40	211.20	203.50	191.70	169.20	169.80	156.60	144.80	135.17	124.45	142.53
	212.60	179.90	176.30	174.50	151.00	134.10	127.50	119.20	118.60	108.53	104.25	105.67
	83.40	68.10	56.80	45.00	32.60	26.70	25.70	19.90	17.90	16.36	12.43	8.91
	100.80	85.00	78.70	66.10	53.40	52.60	44.70	41.00	39.00	46.30	35.38	32.61
	498.80	455.40	425.60	387.00	344.00	297.70	—	—	—	—	—	—
	55.60	63.10	68.60	97.10	113.70	123.20	134.60	162.20	127.10	100.12	102.57	138.64
	0.00	-10.90	0.00	-0.30	0.00	10.80	0.00	0.00	0.00	0.00	0.00	-0.02
	55.60	52.20	68.60	96.80	113.70	134.00	134.60	162.20	127.10	100.12	102.57	138.62
	19.20	21.70	16.70	24.80	28.70	27.90	42.10	41.50	31.90	28.50	25.90	37.32
	37.40	33.10	51.90	72.00	85.00	106.10	92.50	120.70	95.20	71.49	76.55	101.29
	1.04	1.06	1.33	1.67	1.96	2.54	2.22	2.68	10.82	8.18	8.98	11.50
Key metrics
	239.80	205.30	204.10	207.90	199.70	213.30	205.00	223.10	184.00	162.78	150.38	180.14
	20.30%	19.10%	20.50%	21.60%	22.90%	26.80%	26.50%	28.70%	26.70%	25.70%	24.80%	27.60%
	3.20%	3.10%	5.20%	7.50%	9.80%	13.30%	12.00%	15.50%	13.80%	11.30%	12.60%	15.50%
	—	1.80%	—	2.60%	—	3.30%	—	—	—	—	—	—
	35.30%	34.80%	29.20%	23.60%	26.60%	25.70%	27.50%	19.10%	—	—	—	—
	-56.00%	-68.80%	-43.90%	-40.30%	-10.70%	48.40%	20.80%	19.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21
Income statement
	4,212	3,905	3,035	2,498	2,198	1,651	1,330
	35.50	26.20	31.90	13.06	25.87	20.26	10.16
	3,964	3,588	2,520	2,051	1,753	1,224	1,061
	0.00	0.00	0.00	—	—	—	282.64
	911.00	841.80	640.40	536.87	474.49	367.50	—
	743.30	681.70	499.50	422.37	346.44	261.91	220.21
	253.30	202.50	90.30	47.03	30.55	16.03	32.50
	330.60	283.20	177.20	146.55	129.26	72.67	69.54
	1,767	1,612	1,126	—	—	—	—
	284.40	342.50	547.30	459.91	470.08	447.34	279.01
	-11.20	-11.20	10.80	0.00	14.83	0.00	0.00
	273.20	331.30	558.10	459.91	484.91	447.34	279.01
	82.40	91.90	143.30	123.63	119.09	114.32	73.54
	194.40	242.00	414.80	336.01	365.81	343.80	205.48
	5.10	6.03	9.61	38.75	42.03	41.88	26.87
Key metrics
	857.10	817.00	825.60	653.49	644.72	536.04	381.05
	20.35%	20.90%	27.20%	26.20%	29.30%	32.50%	28.70%
	4.61%	6.20%	13.70%	13.50%	16.60%	20.80%	15.50%
	—	8.20%	13.20%	—	—	—	—
	—	28.60%	21.50%	13.70%	33.10%	24.10%	—
	—	-41.70%	23.40%	-8.10%	6.40%	67.30%	—
	—	-917.10	-427.10	—	—	—	—
	—	2.11	1.40	—	—	—	—
	—	1.27	1.06	—	—	—	—
	—	3,189	2,501	—	—	—	—
	—	30.7	22.9	—	—	—	—
Balance sheet
	—	7,759	5,736	—	—	—	—
	—	937.40	697.30	—	—	—	—
	—	55.40	56.00	—	—	—	—
	—	554.20	395.40	—	—	—	—
	—	96.90	64.00	—	—	—	—
	—	56.80	37.70	—	—	—	—
	—	4,186	2,199	—	—	—	—
	—	322.80	269.10	—	—	—	—
	—	1,239	836.20	—	—	—	—
	—	3,244	2,557	—	—	—	—
	—	571.40	269.50	—	—	—	—
	—	2,673	2,287	—	—	—	—
	—	2,558	2,419	—	—	—	—
Cash flow
	—	510.80	581.80	—	—	—	—
	—	-1,452	-1,116	—	—	—	—
	—	940.30	543.10	—	—	—	—
	—	1,428	1,009	—	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	483.60	456.20	441.90	430.00	373.40	345.90	347.50	363.30	327.40	304.85	302.06	316.25
	30.70	17.60	14.30	12.50	12.20	24.20	20.60	6.60	5.30	3.90	4.23	3.57
	425.50	378.00	358.40	356.10	305.90	260.30	266.20	270.80	251.10	241.28	228.58	230.79
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—	—
	99.90	91.00	86.00	91.70	78.10	70.70	75.20	69.10	64.50	59.43	61.28	67.19
	84.90	72.00	74.40	76.10	68.20	58.20	57.10	59.60	61.50	56.12	54.15	55.86
	32.80	26.80	21.60	17.80	12.50	8.10	6.70	4.60	3.80	2.31	1.22	0.05
	27.30	25.50	22.60	20.50	17.50	15.10	14.90	14.00	13.70	20.41	12.78	12.79
	184.50	163.10	158.30	156.30	131.90	107.60	—	—	—	—	—	—
	88.80	95.80	97.80	86.40	79.70	109.80	101.90	99.10	81.60	67.47	77.71	89.02
	0.00	-6.70	0.00	-0.30	0.00	10.80	—	—	—	—	—	—
	88.80	89.10	97.80	86.10	79.70	120.60	101.90	99.10	81.60	67.47	77.71	89.02
	22.30	23.20	25.30	22.60	20.90	27.00	25.40	26.90	20.90	19.27	19.35	22.86
	66.50	65.90	72.50	63.50	58.80	93.60	76.50	72.20	60.70	48.19	58.35	66.16
	1.66	1.65	1.81	1.59	1.47	2.34	1.91	1.80	7.58	6.02	7.29	8.27
Key metrics
	148.90	141.40	142.00	124.40	109.70	143.80	123.50	117.70	99.10	90.19	91.71	101.86
	30.80%	31.00%	32.10%	28.90%	29.40%	41.60%	35.50%	32.40%	30.30%	29.60%	30.40%	32.20%
	13.80%	14.40%	16.40%	14.80%	15.70%	27.10%	22.00%	19.90%	18.50%	15.80%	19.30%	20.90%
	—	3.10%	—	3.30%	—	4.50%	—	—	—	—	—	—
	29.50%	31.90%	27.20%	18.40%	14.10%	13.50%	15.00%	14.90%	—	—	—	—
	13.10%	-29.60%	-5.20%	-12.00%	-3.10%	94.20%	31.10%	9.10%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21
Income statement
	1,812	1,702	1,384	1,222	1,132	1,143	932.69
	75.10	56.60	56.70	15.53	23.50	24.17	9.62
	1,518	1,398	1,048	919.41	818.19	796.55	688.04
	0.00	0.00	0.00	—	—	—	195.96
	368.60	346.80	279.50	253.57	230.82	259.42	—
	307.40	290.70	236.40	219.57	187.25	174.02	147.04
	99.00	78.70	23.20	3.66	1.15	4.47	14.78
	95.90	86.10	57.70	58.11	45.30	44.92	44.60
	662.20	609.60	455.90	—	346.93	—	—
	368.80	359.70	392.30	318.17	337.33	371.00	254.26
	-7.00	-7.00	10.80	—	—	—	—
	361.80	352.70	403.10	318.17	337.33	371.00	254.26
	93.40	92.00	100.20	82.83	84.84	92.64	65.61
	268.40	260.70	302.90	235.34	252.49	278.37	188.65
	6.71	6.52	7.57	29.41	31.55	35.04	25.20
Key metrics
	556.70	517.50	484.00	379.94	383.78	420.39	313.64
	30.73%	30.40%	35.00%	31.10%	33.90%	36.80%	33.60%
	14.81%	15.30%	21.90%	19.30%	22.30%	24.30%	20.20%
	—	11.60%	15.10%	—	—	—	—
	—	22.90%	13.30%	8.00%	-1.00%	22.60%	—
	—	-13.90%	28.70%	-6.80%	-9.30%	47.60%	—
	—	-64.00	-58.10	—	—	—	—
	—	1.12	0.97	—	—	—	—
	—	0.60	0.33	—	—	—	—
	—	1,428	681.90	—	—	—	—
	—	43.8	31.4	—	—	—	—
Balance sheet
	—	4,285	3,189	—	—	—	—
	—	433.80	299.40	—	—	—	—
	—	25.10	26.10	—	—	—	—
	—	278.40	187.40	—	—	—	—
	—	39.80	26.30	—	—	—	—
	—	27.00	0.00	—	—	—	—
	—	1,398	723.80	—	—	—	—
	—	113.60	94.40	—	—	—	—
	—	564.70	358.70	—	—	—	—
	—	1,453	708.00	—	—	—	—
	—	349.60	130.90	—	—	—	—
	—	1,103	577.10	—	—	—	—
	—	2,429	2,168	—	—	—	—
Cash flow
	—	292.60	293.60	—	—	—	—
	—	-955.90	-626.60	—	—	—	—
	—	662.30	338.60	—	—	—	—
	—	356.60	351.70	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +14.55%
Sales CAGR 5Y: +12.78%
Sales CAGR 10Y: —
Profit CAGR 3Y: +1.07%
Profit CAGR 5Y: +6.68%
Profit CAGR 10Y: —
Sales YoY (TTM): +26.68%
Profit YoY (TTM): -10.86%

Consolidated

Sales CAGR 3Y: +21.12%
Sales CAGR 5Y: +24.04%
Sales CAGR 10Y: —
Profit CAGR 3Y: -12.87%
Profit CAGR 5Y: +3.33%
Profit CAGR 10Y: —
Sales YoY (TTM): +30.90%
Profit YoY (TTM): -51.92%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 32.50%

Quarter	June 2026	March 2026
Promoter %	32.50%	32.50%

Holder	Type	Holding	Previous	Change
Bhaskara Rao Bollineni	Promoter	25.02%	25.02%	0.00%
Bluebridge Capital Private Limited	Promoter	5.76%	5.76%	0.00%
Sbi Small Cap Fund	Public	5.17%	5.16%	+0.01%
Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund	Public	4.50%	4.43%	+0.07%
Hdfc Small Cap Fund	Public	3.98%	4.16%	-0.18%
Bollineni Seenaiah Naidu	Public	3.93%	3.93%	0.00%
Kotak Small Cap Fund	Public	3.61%	3.61%	0.00%
Invesco India Flexi Cap Fun	Public	3.54%	—	—
Amansa Holdings Private Limited	Public	2.24%	2.24%	0.00%
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund	Public	1.95%	1.96%	-0.01%
Lilac Investments Limited	Public	1.87%	1.87%	0.00%
Sbi Life Insurance Co. Ltd	Public	1.71%	1.72%	-0.01%
Rajyasri Bollinen	Promoter	1.64%	—	—
Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110	Public	1.57%	1.57%	0.00%
Nomura India Investment Fund Mother Fund	Public	1.50%	1.50%	0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Anand Rathi Annual Flagship Conference G-200 Summit 202615 Sep 2026 · Company Update / Analyst / Investor Meet
J.P. Morgan India Conference15 Sep 2026 · Company Update / Analyst / Investor Meet
The Company has entered into Operations and Management Agreement with Sarvottam Health Care Private Limited, Kakinada, Andhra Pradesh.10 Sep 2026 · Company Update / Memorandum of Understanding /Agreements
Intimation of schedule of Analyst / Institutional Investor Meeting.7 Sep 2026 · Company Update / Analyst / Investor Meet
Voting results and Scrutinizer''s Report for the 24th AGM held on 27.08.202630 Aug 2026 · AGM/EGM / AGM
Proceedings of 24th Annual General Meeting of the Company27 Aug 2026 · AGM/EGM / AGM
Clarification regarding article appearing in Dealstreetasia.com26 Aug 2026 · Company Update / General
KIMS has entered into Operations and Management agreement with Aurevia Hospitals Private Limited20 Aug 2026 · Company Update / General
Allotment of Warrants20 Aug 2026 · Company Update / Allotment of Equity Shares
Transcript of earnings conference call with investors held on 04 August, 20268 Aug 2026 · Company Update / Earnings Call Transcript
Intimation of receipt of the In-Principal Approval for the issue and allotment of warrants to promoters/promoters group on a preferential basis7 Aug 2026 · Company Update / General
Copy of Newspaper Publication towards intimation of notice of 24th Annual General Meeting of the Company.6 Aug 2026 · Company Update / Newspaper Publication
Letter to Shareholders Regarding Annual Report5 Aug 2026 · Company Update / General
BRSR for the FY 2025-265 Aug 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
24th Annual Report for the FY 2025-265 Aug 2026 · Others / Reg. 34 (1) Annual Report
24th Annual General Meeting Scheduled to be held on 27th August, 20265 Aug 2026 · AGM/EGM / AGM
Emkay Confluence 20264 Aug 2026 · Company Update / Analyst / Investor Meet
Newspaper Publication on the unaudited financial results for 01st quarter ended 30th June, 2026.4 Aug 2026 · Company Update / Newspaper Publication
Audio Recording of Conference Call with Investors/ Analysts for Q1 FY27.4 Aug 2026 · Company Update / Analyst / Investor Meet
Monitoring Agency Report for the Quarter ended June 30, 2026.3 Aug 2026 · Company Update / Monitoring Agency Report
Statement of Deviation for quarter ended June 30, 2026.3 Aug 2026 · Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation
Press Release for Q1FY273 Aug 2026 · Company Update / Press Release / Media Release
Investor Presentation3 Aug 2026 · Company Update / Investor Presentation
Financial Results for Q1 2026-273 Aug 2026 · Result / Financial Results
Outcome of the Board meeting held on 03rd August 20263 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation about a conference call for analysts and investors28 Jul 2026 · Company Update / Analyst / Investor Meet
Krishna Institute Of Medical Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 ,inter alia, to consider and approve We hereby ....28 Jul 2026 · Board Meeting / Board Meeting
Certificate under regulation 74(5) of SEBI (DP) Regulations, 201817 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Voting Results and Scrutinizer Report11 Jul 2026 · AGM/EGM / EGM
Proceedings of the EGM9 Jul 2026 · AGM/EGM / EGM
Corrigendum to Notice of the Extraordinary General Meeting of the Company scheduled to be held on 9 July 20264 Jul 2026 · AGM/EGM / EGM
Closure of Trading Window for Q1FY27.25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Approval received from Stock Exchanges for listing of 1,98,67,549 equity shares through QIP.23 Jun 2026 · Company Update / General
Outcome For Allotment19 Jun 2026 · Company Update / Qualified Institutional Placement
outcome19 Jun 2026 · Company Update / Qualified Institutional Placement
Newspaper Publication - Intimation about EGM18 Jun 2026 · Company Update / Newspaper Publication
EGM will be held on Thursday, 9th July, 2026 at 4:00 PM17 Jun 2026 · AGM/EGM / EGM
Extraordinary General Meeting of the members of the Company will be held on Thursday 9 July, 2026 at 4:00 PM17 Jun 2026 · AGM/EGM / EGM
Approval of Qualified Institutional Placement16 Jun 2026 · Company Update / General
Audited Standalone and Consolidated Financial Statements for the Financial Year ended 31st March 2026.16 Jun 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Stock Split From Rs.10/- to Rs.2/-	13 Sep 2024	13 Sep 2024	—

Board meetings

3 Aug 2026 Board Meeting - Financial Results